Trial intelligence / Profile preview

Nebido for anemia management in hypogonadal men on hemodialysis

2011-005439-20Phase 4Completed

Sponsor
Dept of Renal medicine
Start
Dec 2011
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of testosterone undecanoate in Hypoandrogenism (TD) and anaemia (2 arms), sponsored by Dept of Renal medicine. Primary endpoint: Change in ESA requirements. Started Dec 2011; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

Hypoandrogenism (TD)anaemia

Beyond the preview

Go deeper on 2011-005439-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005439-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call